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Gestational diabetes mellitus (GDM) is one of the most common pregnancy 
complications. It has been shown that a history of GDM is associated with an increased risk 
of incident type 2 diabetes in women. In this project, we aim to investigate 1) the trend of 
GDM incidence in Louisiana State University Health Care Services Division (LSUHCSD) 
hospital system during 1997 to 2009; 2) the race-specific association between a history of 
GDM and the risk of incident type 2 diabetes and how the risk changes over years after the 
index pregnancy.  
We conducted a retrospective study among women aged 13-50 years. Pregnancies, 
GDM cases and type 2 diabetes cases were identified by using the International Classification 
of Disease (ICD) -9 code from the Louisiana State University Hospital-Based Longitudinal 
Study (LSUHLS) database. The annual incidence of GDM and it standard error (SE) were 
calculated. Cox proportional hazards regression models were used to estimate the association 
of a history of GDM with the risk of incident type 2 diabetes. The association between 
previous GDM and the risk of type 2 diabetes in different postpartum periods was examined 
using logistic regression.  
The incidence of GDM increased in most years from 1997 to 2009 and reached a peak 
in 2002. The incidence of GDM increased with age and reached the peak at 35-39 years of 
age. Among the three study races, Asians had a significantly higher incidence of GDM than 
Whites and African Americans. Between 1990 and 2009, 1,142 GDM women and 18,856 
non-GDM women presented their first record of pregnancy in the LSUHLS database. During 
a mean follow-up of 8.6 years, 1,067 women without a history of GDM and 327 women with 
a history of GDM developed type 2 diabetes. The multivariable-adjusted (age, smoking, 
income, postpartum body mass index (BMI), postpartum systolic blood pressure, and race) 
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hazard ratio of type 2 diabetes suggested that a history of GDM is a strong predictor of 
subsequent type 2 diabetes among Louisiana women, especially among African American 





Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance 
with onset or first recognition during pregnancy,(ADA, 2003) is a major health problem 
affecting about 7% of pregnancies in the United States.(ADA, 2003) Recent data have shown 
a substantial rise in the incidence of GDM among White, African American, and Asian 
women (Dabelea et al., 2005b; Ferrara et al., 2004) along with the increase in the prevalence 
of obesity (Flegal et al., 2010; Hedley et al., 2004; WHO, 2000). It has been estimated that 
GDM increased national medical costs by $636 million in 2007 (Chen et al., 2009). Although 
most women with GDM regain normal glucose tolerance after delivery, many of them are 
featured with metabolic disorders in postpartum and later life. For instance, women with prior 
GDM are at increased risk of subsequent type 2 diabetes, impaired glucose tolerance (IGT), 
obesity, hypertension, dyslipidemia, and the metabolic syndrome (Carr et al., 2006; Flegal et 
al., 2010; Hedley et al., 2004; Lauenborg et al., 2005; WHO, 2000). Offspring of women with 
GDM also have increased risk of obesity and diabetes in childhood and early adulthood 
(Dabelea, 2007). Recently, an increase in the prevalence of GDM was reported in Colorado 
(Dabelea et al., 2005b) and California (Ferrara et al., 2004), the United States, and in 
Tianjin(Zhang et al., 2011), China using locally available data.  
Type 2 diabetes, a common and serious condition associated with reduced life 
expectancy and considerable morbidity, has posed a great burden on patients, their families, 
and health care systems.(ADA, 2011) Several studies have demonstrated that type 2 diabetes 
can be prevented or delayed by implementing lifestyle modifications (Knowler et al., 2002; 
Tuomilehto et al., 2001). In order to be cost-effective, lifestyle interventions to prevent or 
delay type 2 diabetes should be directed toward individuals at increased risk for the disease 
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(Eddy et al., 2005; Herman et al., 2005). Therefore, it is of great importance to find clinical 
predictors of type 2 diabetes.  
The present study aims to assess the trends in the annual incidence of GDM and the 
race-specific association between a history of GDM and incidence of type 2 diabetes and to 
evaluate how the risk changes over years after the index pregnancy by using the well-
characterized Louisiana State University Hospital-Based Longitudinal Study (LSUHLS) 
database. 
 Justification 
Although long-term trends of GDM are available at the national level, they are less 
clear for population subgroups especially those on middle or low income and also at high risk 
of obesity. Furthermore, it is also unclear to what extent a history of GDM could predict 
incident type 2 diabetes in the population of Louisiana which has the fourth highest 
prevalence of diabetes in the United States and whether there is a racial difference between 
the association of GDM and type 2 diabetes.  
The present study, which is part of the LSUHLS, utilized a cohort design. The 
subjects involved in this study were women served by Louisiana State University Health Care 
Services Division (LSUHCSD) hospitals, most of which were from middle or low income 
families. The present study would provide important information for understanding the scope 
and burden of GDM and type 2 diabetes in Louisiana women especially those on middle or 
low income. 
Research Questions 
1. What is the trend in the annual incidence of GDM in the women served by 
LSUHCSD hospitals? 
2. What is the association between a history of GDM and the risk of incident type 2 
diabetes in the women served by LSUHCSD hospitals? 
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3. What is the racial difference between the associations of GDM and the risk of incident 
type 2 diabetes in the women served by LSUHCSD hospitals? 
Hypotheses 
1.  The incidence of GDM increased over years in the women served by LSUHCSD 
hospitals. 
2. A history of GDM predicted subsequent type 2 diabetes among the women served by 
LSUHCSD hospitals. 
3. In the LSUHCSD hospital system, African American women with a history of GDM 
showed a higher relative risk for incident type 2 diabetes than White women with a 
history of GDM. 
Limitations 
1. The results of the present study, to be conducted with women from middle or low-
income families in Louisiana, will not be generalized to other regions and socio-
economic groups in the United States. 
2. Even though the analysis used to estimate the association between a history of GDM 
and type 2 diabetes was adjusted for age, smoking, income, BMI, systolic blood 
pressure, and race, residual confounding due to the measurement error in the 
assessment of confounding factors, unmeasured factors such as physical activity, 
education, dietary factors and a family history of diabetes, were not determined thus, 
cannot be excluded.  
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REVIEW OF LITERATURE 
GDM 
GDM, defined by the American Diabetes Association (ADA) as any degree of 
glucose intolerance with onset or first recognition during pregnancy, is a major health 
problem affecting about 7% of pregnancies in the U.S.(ADA, 2003) Recent data have shown 
a substantial rise in the incidence of GDM among women of various ethnic/racial 
backgrounds.(Dabelea et al., 2005b; Ferrara et al., 2004) GDM is associated with adverse 
maternal and fetal outcomes, such as cesarean delivery, embryopathy, birth trauma and fetal 
macrosomia.(ADA, 2003; Ecker and Greene, 2008) Offspring of women complicated with 
GDM have increased risk of obesity, glucose intolerance, and diabetes in childhood and early 
adulthood.(Dabelea, 2007) Also, a history of GDM increases the risk of having subsequent 
type 2 diabetes and IGT after pregnancy.(Bellamy et al., 2009; Dornhorst and Rossi, 1998; 
Kim et al., 2002) In addition, women with prior GDM are also at increased risk of 
cardiovascular disease risk factors, such as obesity, hypertension, dyslipidemia, and the 
metabolic syndrome.(Carr et al., 2006; Lauenborg et al., 2005) Therefore, studying GDM 
would facilitate people’s understanding on GDM as well as other diseases.  
International Criteria for GDM Diagnosis 
One critical issue in studying GDM is to understand the different diagnostic criteria of 
GDM. The major diagnostic criteria of GDM used around the world are listed in Table 1. 
O’Sullivan, a pioneer in the study of GDM, established the oral glucose tolerance test (OGTT) 
for assessing the upper limit of glycemic normality in pregnancy in 1964.(O'Sullivan and 
Mahan, 1964) The O’Sullivan criteria were endorsed by the National Diabetes Data Group 
(NDDG) in 1979 and were regarded as the most appropriate diagnostic method for GDM. 
(National Diabetes Data Group, 1979) In 1982, Carpenter and Coustan published new criteria  
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Table 1. GDM diagnostic criteria 
Name, Year Diagnostic Criteria 
WHO, 1985 
(WHO, 1985) 
2-h 75 g OGTT: (One or more must be met or exceeded.) 
    Fasting: ≥ 140 mg/dl (7.8 mmol/l) 
    2-h: ≥ 200 mg/dl (11.1 mmol/l) 
WHO, 1999 
(Alberti and Zimmet, 1998) 
2-h 75 g OGTT: (One or more must be met or exceeded.) 
    Fasting: ≥ 126 mg/dl (7.0 mmol/l) 
2-h: ≥ 200 mg/dl (11.1 mmol/l) 
    IGT: 2-h: 140-199 mg/dl  
NDDG, 1979 
(National Diabetes Data Group, 1979) 
100 g OGTT: (Two or more must be met or exceeded.) 
    Fasting: ≥ 105 mg/dl (5.8 mmol/l) 
    1-h: ≥ 190 mg/dl (10.6 mmol/l) 
    2-h: ≥ 165 mg/dl (9.2 mmol/l) 
    3-h: ≥ 145 mg/dl (8.1 mmol/l) 
O’Sullivan & Mahan, 1964 (O'Sullivan and 
Mahan, 1964) 
100 g OGTT: (Two or more must be met or exceeded.) 
    Fasting: ≥ 104 mg/dl (5.8 mmol/l) 
    1-h: ≥ 190 mg/dl (10.6 mmol/l) 
    2-h: ≥ 166 mg/dl (9.2 mmol/l) 
    3-h: ≥ 140 mg/dl (8.1 mmol/l) 
Carpenter & Coustan, 1982 
(Carpenter and Coustan, 1982)  
100 g OGTT: (Two or more must be met or exceeded.) 
    Fasting: ≥ 95 mg/dl (5.3 mmol/l) 
    1-h: ≥ 180 mg/dl (10.0 mmol/l) 
    2-h: ≥ 155 mg/dl (8.6 mmol/l) 













100 g OGTT: (Two or more must be met or exceeded.) 
    Fasting: ≥ 95 mg/dl (5.3 mmol/l) 
    1-h: ≥ 180 mg/dl (10.0 mmol/l) 
    2-h: ≥ 155 mg/dl (8.6 mmol/l) 
    3-h: ≥ 140 mg/dl (7.8 mmol/l) 
Or 75 g OGTT: (Two or more must be met or exceeded.) 
    Fasting: ≥ 95 mg/dl (5.3 mmol/l) 
    1-h: ≥ 180 mg/dl (10.0 mmol/l) 
    2-h: ≥ 155 mg/dl (8.6 mmol/l) 
Or fasting ≥ 126 mg/dl (7.0 mmol/l) 
Or a casual  ≥ 200 mg/dl (11.1 mmol/l) 






Table 1 continued 
ADA, 2011 
(ADA, 2011) 
75 g OGTT: (One or more must be met or exceeded.) 
    Fasting: ≥ 92 mg/dl (5.1 mmol/l) 
    1-h: ≥ 180 mg/dl (10.0 mmol/l) 
    2-h: ≥ 153 mg/dl (8.5 mmol/l) 
Or a casual ≥ 200 mg/dl (11.1 mmol/l) 
Or A1C≥6.5% 
ADA: American Diabetes Association; NDDG: National Diabetes Data Group;  
 
for GDM based on the same testing procedure but with different thresholds. (Carpenter and 
Coustan, 1982)  There was an adjustment for the threshold because hexokinase method, a 
more precise enzymatic method than the Somogyi-Nelson method, had developed to evaluate 
the plasma glucose levels. The diagnostic guidelines for GDM of the ADA were based on 
these criteria. Of note is that, in 2011, the Hemoglobin A1C test for the diagnosis of GDM 
was officially accepted by the ADA.(ADA, 2011) The World Health Organization (WHO) 
used a two step procedure: 2-hour 75 g OGTT to diagnose GDM.(WHO/IDF Consultation, 
2006)  In 1999, the thresholds were lowered in order to increase the sensitivity in detecting 
glucose intolerance and have been used ever since. (Alberti and Zimmet, 1998)  
Although several studies showed that the above GDM diagnostic criteria have 
successfully predicted adverse maternal, fetal and neonatal outcomes,(Gokcel et al., 2002; 
Pennison and Egerman, 2001; Retnakaran et al., 2009; Schmidt et al., 2001) large 
discrepancies exist in these criteria in their ability to identify women with GDM. (Agarwal et 
al., 2005; Ferrara et al., 2002) For example, the study conducted by Agarwal et al in 2005 
(Agarwal et al., 2005), which aimed to highlight the variation between six well-accepted 
international GDM diagnostic criteria, showed that GDM prevalence between any two 
criteria was significantly different. In addition, the capacity of the six criteria to predict 
adverse pregnancy outcome were also different.(Agarwal et al., 2005) Although it is 
recognized that diagnostic criteria usually performed better in the population they were 
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developed in than in a different population because of different population characteristics, the 
large discrepancies seen in this study suggested that more research is needed to help reach a 
international consensus on optimal GDM diagnostic criteria.  
Worldwide GDM Prevalence 
 GDM prevalence/incidence data were available for all six WHO regions. The reported 
prevalence/incidence ranged from 1.7% to 22.3%.(Murgia et al., 2006; Ostlund and Hanson, 
2004) The studies which reported GDM prevalence/incidence across at least one year are 
listed in Table 2. (The studies conducted in the United States are listed in the next section)  
Among these studies, one study conducted in the South-east Asia region reported the highest 
GDM prevalence: 14.2%, followed by the study conducted in the Eastern Mediterranean 
region which reported a GDM incidence of 13.5%. The prevalence of the Western Pacific 
region only ranged from 2.6%-3.8%, which is similar with the reported prevalence in most of 
the studies conducted in the European region. The reason might be that the Pacific islands 
were not represented in this region. Underrepresentation was also a problem in the other 5 
regions. Moreover, different criteria were used to diagnose GDM in these studies which make 
it difficult to make comparison between studies and few population based studies were 
available. Therefore, in order to clearly understand the economic burden caused by GDM, 
future studies are needed to make the exact magnitude of GDM prevalence clear.  
GDM Prevalence in the United States 
GDM prevalence data were available for 17 states in the United States: 
Alaska,(Murphy et al., 1993) California,(Esakoff et al., 2005a) (Ferrara et al., 2004) 
(Lawrence et al., 2008) Colorado,(Dabelea et al., 2005a) Georgia,(Cho, 2008) Hawaii,(Pedula 
et al., 2009) Illinois,(Dooley et al., 1991) Indiana,(Indiana State Department of Health, 2009) 
Montana,(Taryn Hall et al., 2008) Nebraska, (Rettig, 2003) New York, (Rosenberg et al., 
2005a) North Carolina,(Jung, 2008) (Thorpe et al., 2005) Oklahoma, (Page, 2003) Oregon, 
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Table 2. Worldwide prevalence/incidence of GDM 











(Schmidt et al., 2000) 
1991-
1995 
7.6 5,004 WHO  
 Canada 
(Aljohani et al., 2008) 
2000-
2004 
3.7 71,527 NDDG 
Europe Netherlands 
(Weijers et al., 1998) 
1992-
1997 
2 1,640 WHO  
 Sweden 
(Aberg et al., 2002) 
1991-
1999 
2.5 12,382 WHO  
 Italy 
(Di Cianni et al., 2003) 
1995-
2001 
8.7 3,950 Carpenter & 
Coustan 
 Denmark 
(Jensen et al., 2003) 
1999-
2000 
2.4 5,235 WHO  
 Sweden 
(Ostlund and Hanson, 2004) 
1994-
1996 
1.7 3,616 WHO  
 Finland 
(Poyhonen-Alho et al., 2005) 
1996-
1998 
2.8 523 Carpenter & 
Coustan 
 Switzerland 
(Noussitou et al., 2005) 
2000-
2002 
2.7 5,788 NDDG 
 Turkey 
(Tanir et al., 2005) 
1995-
2004 





(Al Mahroos et al., 2005) 
2001-
2002 
13.5 10,495 Carpenter & 
Coustan 
South-east Asia China 
(Ko et al., 2002) 
1990-
1994 
14.2 942 WHO  
 Japan 
(Maegawa et al., 2003) 
1999-
2001 
2.9 749 ADA  
 India 
(Zargar et al., 2004) 
1999-
2002 
3.8 1,000 Carpenter & 
Coustan 
 Pakistan 
(Chandna et al., 2006) 
2003-
2004 
8.5 633 ADA  
 China 
(Zhang et al., 2011)  
1999-
2008 
4.9 105,473 WHO  
Western Pacific New Zealand 
(Yapa and Simmons, 2000) 
1994-
1995 
2.6 4,885 Carpenter & 
Coustan 
 Australia 
(Anna et al., 2008) 
1995-
2005 




(Lockwood, 2008) Pennsylvania, (Pennsylvania Department of Health, 2010) 
Texas,(Ramadhani et al., 2004) Utah, (Barnard and Bloebaum., 2003) and West 
Virginia,(Wise and Taylor, 2002).  The state that reported the highest GDM prevalence is 
Texas (7.9% 2001), while the state that reported the lowest GDM prevalence is Indiana (0.8% 
in 2008). The differences in the GDM prevalence might be partly explained by the different 
race/ethnicity composition and the different age composition of the study samples in these 
studies. Since some of the studies were not performed on a state representative sample, the 
studies were not conducted during the same period and prevalence data are still lacking in 33 
states, further studies are needed to understand the magnitude of GDM across the United 
States.  
 In the studies that explored the race/ethnicity difference in the prevalence of GDM in 
the Unites States, most studies indentified Asian as the race with the highest GDM 
prevalence followed by Hispanic then African American and White.(Berkowitz et al., 1992; 
Dabelea et al., 2005b; Esakoff et al., 2005b; Getahun et al., 2008a; Green et al., 1990; Kieffer 
et al., 2001; Rosenberg et al., 2005b; Savitz et al., 2008; Shen et al., 2005; Thorpe et al., 2005) 
Only one study reported a lower GDM prevalence in Hispanic than in White, while two 
studies showed a higher GDM prevalence in White than in African American. Higher 
adiposity per unit BMI, poor medical care, short stature and genetic factors may contribute to 
the higher GDM incidence in Asians.(Anastasiou et al., 1998; Chu et al., 2009; Groop and 
Orho-Melander, 2001; Jang et al., 1998; WHO expert consultation, 2004)  
 The studies which provided the trends of GDM prevalence/incidence are listed in 
Table 3. Among all of the studies there was a trend of increasing prevalence/incidence across 
time with the relative increase ranging from 10% to 121%.  Factors such as the diagnosis 




Table 3. Change of GDM prevalence/incidence in the United States  
Setting Study period 
(years) 
Change of GDM 
Prevalence/incidence (%) 
Relative increase in GDM 
prevelance/incidence (%) 
Sample Size Diagnostic Criteria 
United States 
(Getahun et al., 2008a) 
1989-2004 1.9-4.2 121 58,922,266 ADA (1997)/ADA (1997) /ADA 
(2000) 
Utah 
(Barnard and Bloebaum., 2003) 
1990-2001 1.4-2.3 64 NA NA 
New York City 
(Thorpe et al., 2005) 
1990-2001 2.6-3.8 46 125,663-110,340 NA 
Northern California  
(Ferrara et al., 2004) 
1991-2000 5.1-6.9 35 21,655-30,135 ADA (2000) 
Colorado 
(Dabelea et al., 2005b) 
1994-2002 2.1-4.1 95 3,644-4,079 NDDG 
Montana 
(Taryn Hall et al., 2008) 
1995-2006 2.2-2.8 27 NA NA 
Southern California 
(Lawrence et al., 2008) 





the study samples may contribute to the difference in the estimates. Of note, none of these 
studies focused on a middle or low income population. 
History of GDM and Type 2 Diabetes Risk 
The effect of previous GDM on subsequent type 2 diabetes has been studied 
extensively worldwide (Albareda et al., 2003; Chodick et al., 2010; Feig et al., 2008; 
Gunderson et al., 2007; Krishnaveni et al., 2007; Lee et al., 2007; O'Sullivan, 1991).  These 
studies consistently recognized GDM as an important risk factor for subsequent type 2 
diabetes. One early meta-analysis of six controlled follow-up studies has indicated that  the 
overall relative risk for developing diabetes after GDM was 6.0 (Cheung and Byth, 2003). In 
the more recent meta-analysis of 20 cohort studies (Bellamy et al., 2009), women with a 
history of GDM were associated with at least a seven-fold increased risk of incident type 2 
diabetes.  
In light of a growing body of evidence, it is generally accepted that the progression to 
type 2 diabetes of parous women with previous GDM is faster than that of parous women 
without previous GDM (Albareda et al., 2003; Bellamy et al., 2009; Cheung and Byth, 2003; 
Chodick et al., 2010; Di Cianni et al., 2010; Feig et al., 2008; Kim et al., 2002; Lee et al., 
2007; O'Sullivan, 1991). However, the exact mechanism linking GDM to type 2 diabetes is 
not well understood. Because GDM and type 2 diabetes share the same risk factors such as 
obesity, physical inactivity, advanced age, ethnic group and family history of diabetes, and 
the two conditions are strongly associated with each other, GDM and type 2 diabetes are now 
regarded to share a common genetic background more than ever before (Cho et al., 2009; Di 
Cianni et al., 2010; Lauenborg et al., 2009). This hypothesis was confirmed by two recent 
studies which showed that women with previous GDM more frequently display some alleles 
associated with the high risk of type 2 diabetes (Cho et al., 2009; Lauenborg et al., 2009). 
Since several intervention studies have showed that it is possible to delay or prevent the 
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development of type 2 diabetes among those at high risk (Knowler et al., 2002; Tuomilehto et 
al., 2001), and a recent clinic trial (Ratner et al., 2008) proved that women with a history of 
GDM who remained at a high risk of developing diabetes benefited from either lifestyle or 
pharmacologic interventions, determining the true risk of type 2 diabetes in women with a 






LSUHCSD operates 7 public hospitals and affiliated clinics in different areas in 
Louisiana which provide quality medical care to residents of Louisiana, regardless of their 
income or insurance coverage. Overall, LSUHCSD facilities have served about 1.6 million 
unique patients (35% of the Louisiana population) since 1990. In the population served by the 
LSUHCSD hospitals, about 46% of patients qualify for free care (by virtue of being low 
income and uninsured), about 10% of patients are self-pay (uninsured, but incomes not low 
enough to qualify for free care), about 20% of patients are covered by Medicaid, about 14% 
of patients have Medicare, and about 10% of patients are covered by commercial insurance. 
The LSUHCSD, the division responsible for the management of the LSUHCSD facilities, has 
access to the administrative, anthropometric, laboratory, and the clinical diagnosis data 
collected at these facilities. All these data are available in electronic form since 1990 for both 
inpatients and outpatients (the LSUHCSD Disease Management Evaluation Database). Using 
these data, we have set up the LSUHLS database to follow patients with major chronic 
diseases. Patients’ information on birth date, race, sex, address, types of insurance, family 
income, smoking habits, date of examination, measurements of height, weight and blood 
pressure for each visit, diagnosis of various diseases and date of diagnosis, laboratory tests, 
and medication history were all included in the LSUHLS database. The cohort of pregnancies, 
which is part of the LSUHLS Study, was identified through the LSUHLS database between 
January 1, 1990, and December 31, 2009. After excluding participants with incomplete data 
on any required variables, the trend analyses include a total of 2,751 GDM incident cases 
among 62,685 pregnancies between 1997 and 2009. After excluding participants with a 
history of diabetes at baseline and participants with incomplete data on any required variables, 
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the association analyses include 1,142 women with a history of GDM and 18,856 women 
without a history of GDM who presented their first record of pregnancy in the LSUHLS 
database between 1990 and 2009. The study was approved by both Pennington Biomedical 
Research Center and LSU Health Sciences Center Institutional Review Boards. 
Assessments 
The gestational women’s characteristics, such as age, race-ethnicity, postpartum blood 
pressure，postpartum BMI, smoking status, and family income, date of pregnancy, and 
reproductive history were also extracted from the computerized hospitalization records. In the 
LSUHLS dataset, race-ethnicity was classified as White, African American, Asian, Hispanic, 
American Indian, native Hawaiian or Pacific Islander, other, and unknown. In the trend 
analyses, maternal age was categorized as 15.0-19.9, 20.0-24.9, 25.0-29.9, 30.0-34.9, 35.0-
39.9, and 40.0-50.0 years. The analyses by race-ethnicity specific incidence were restricted to 
the White, African American and Asian because the sample sizes of other races are too small 
(e.g. 229 for American Indian) for meaningful analyses (i.e. stratified by age and year). In the 
association analyses, maternal age was categorized as 13.0-29.9, 30.0-49.9, and 40.0-50.0 
years. The analyses were restricted to the White, African American, Asian, Hispanic, and 
American Indian. Smoking information was recorded as yes or no based on the answers to the 
question: "Have you used tobacco in the past 30 days?" Family income was categorized into 
quartile, ranked from the lowest to the highest. BMI was categorized into normal (<25.0 
kg/m
2
), overweight (<25.0-29.9 kg/m
2
) and obesity (≥30.0 kg/m
2
).  
Ascertainment of Pregnancy and GDM 
Only the first record of pregnancy diagnosis and GDM diagnosis of women aged 13-
50 years were included in the present analyses due to the design of cohort study. Pregnancies 
were identified by using the Ninth Revision of the International Classification of Disease 
15 
 
(ICD) Code v22, v72.42, v23 and 761.5 (ICD-9). GDM cases were identified by using the 
ICD-9 code 648.8.  
Screening and Testing of GDM 
Since 1990, all LSUHCSD hospitals have routinely screened for GDM in all non-
diabetic pregnancies using a two-step standard protocol. At 24–28 weeks, all pregnant 
women including women with previously diagnosed diabetes were offered screening for 
GDM with a 50-g 1-hour OGTT. If pregnant women had a value ≥140 mg/dl, they 1) 
underwent a 100-g 3-hour or a 75-g 2-hour OGTT; 2) had fasting plasma glucose measured, 
or 3) had 2-hour postprandial or random plasma glucose levels measured. 
Validation of GDM 
We conducted a validation study on GDM cases among those who had the laboratory-
documented hyperglycemia identified during pregnancy. The laboratory data were used to 
validate the GDM cases identified by using the ICD-9 code 648.8. Hyperglycemia was 
defined as follows: 1) at least 2 plasma glucose measurements during a 100-g 3-hour or a 75-
g 2-hour OGTT equal or greater than the cutoffs recommended by the ADA (fasting ≥95 
mg/dL; 1-hour ≥180 mg/dL; 2-hour ≥155 mg/dL; 3-hour ≥40 mg/dL);(ADA, 2003) 2) 2-hour 
plasma glucose or random plasma glucose concentration ≥200 mg/dL according to the WHO 
(WHO Consultation, 1999) and ADA recommendation (Genuth et al., 2003); or 3) fasting 
plasma glucose ≥126 mg/dL, 2-hour plasma glucose after a 75-g OGTT between 140 and 199 
mg/dL (IGT), or fasting plasma glucose between 110 (from 1997 to 2003)/100 (from 2003) 
and 125 mg/dL (impaired fasting glucose [IFG]) according to WHO (WHO Consultation, 
1999) and ADA criteria (Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus, 1997; Genuth et al., 2003). Plasma glucose testing results were extracted from the 
LSUHCSD Disease Management Evaluation Database laboratory database, which captures 
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the results of all laboratory tests performed at all LSUHCSD facilities. All the plasma glucose 
measurements were performed by using the hexokinase method at each facility’s laboratory.  
Prospective Follow-up 
Follow-up information was obtained from the LSUHLS database by using the unique 
number assigned to every patient who visits the LSUHCSD hospitals. ICD-9 Code 250.*0 
and 250.*2 were used to identify type 2 diabetes cases during follow-up. Since 1990, 
LSUHCSD’s internal diabetes disease management guidelines call for physician confirmation 
of diabetes diagnoses by applying the ADA(Genuth et al., 2003) or the WHO criteria(Alberti 
and Zimmet, 1998): a fasting plasma glucose level ≥140 mg/dL (≥126 mg/dL from 1998); 2-
hour glucose level ≥200 mg/dL after a 75-g 2-hour OGTT; one or more classic symptoms 
plus a random plasma glucose level ≥200 mg/dL. Follow-up of each cohort member 
continued until the date of the diagnosis of type 2 diabetes, the date of the last visit if the 
subject stopped using LSUHCSD hospitals, or May 31
st
, 2010.  
Statistical Analyses 
The number of pregnancies and GDM cases of each study years among each age 
group were reported. The yearly age-specific incidence of GDM and the yearly race-
ethnicity-specific incidence of GDM were calculated by using General Linear Model (logistic 
regression). The linear trend in incidence across time was tested using incidence GDM as the 
outcome variable and year as a continuous variable in the model after adjustment for age. The 
age-standardized incidence was calculated by the direct method to the year 2000 Census 
population using the age groups 15.0-19.9, 20.0-24.9, 25.0-29.9, 30.0-34.9, 35.0-39.9, and 
40.0-50.0 years.(U.S.CensusBureau, 2000)  
Differences in risk factors at baseline of GDM women and non-GDM women were 
tested using General Linear Model after adjustment for age. Cox proportional hazards 
regression models were used to estimate overall the association of a history of GDM with the 
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risk of incident type 2 diabetes. The analyses were first carried out adjusting for age, and 
further for smoking, income, BMI, systolic blood pressure, and race. The association between 
a history of GDM and the risk of type 2 diabetes in different postpartum periods was 
examined using logistic regression with adjustment for the above confounding factors. 
Postpartum year was categorized as <1, 1.0-3.9, 4.0-5.9, 6.0-7.9, 8.0-9.9, and ≥10.0 years. 
Statistical significance was considered to be P < 0.05.  Statistical analyses were performed 
with PASW for Windows, version 19.0 (IBM SPSS Inc, Chicago, III) or SAS for Windows, 
version 9.12 (SAS Institute, Cary, NC). 
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RESULTS AND DISCUSSION 
Results 
GDM Incidence in Louisiana 
Table 4 shows the number of pregnancies and GDM cases by years and age groups. 
From 1997 to 2009, 62,685 women aged 15-50 years with their first record of pregnancy 
were identified. Among them, a total of 2,751 women had pregnancies complicated by GDM. 
The mean age of pregnancy was 24.3 ± 0.02 (standard error [SE]) years and did not change 
by year.   
The annual incidence of GDM by age groups is presented in Table 5. The crude 
incidence of GDM increased from 4.1% (SE 0.3) in 1997 to 5.3% (SE 0.3) in 2002 (increased 
by 29.3%) and then declined from 4.8% (SE 0.3) in 2003 to 4.4% (SE 0.4) in 2009. Exclusion 
of the women who were diagnosed with diabetes before they were diagnosed with GDM did 
not appreciably change the observed trend: the crude incidence of GDM increased from 4.0% 
(SE 0.2) in 1997 to 4.8% (SE 0.3) in 2002 (increased by 20%) and then declined from 4.4% 
(SE 0.3) in 2003 to 4.2% (SE 0.4) in 2009. The age-standardized incidence of GDM 
increased from 5.8% in 1997 to 8.3% in 2002 (increased by 29.3%) and then changed from 
6.7% in 2003 to 7.5% in 2009. The total crude and age-standardized average incidences of 
GDM were 4.4% and 6.3%, respectively. The incidence of GDM increased with age and 
reached the peak at 35-39 years of age (9.1%) and then decreased in women who were 40-50 
years old (7.4%). Compared with women aged 15-19 years, women aged 30-34 years had 2.6 
times higher risk of GDM, and women aged 35-39 had 2.9 times higher risk of GDM. The 
trend of GDM incidence in the six age groups did not change appreciably (all p >0.1). 
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Table 4. Number of first time pregnancies and incidence of GDM by age and year in the LSUHCSD Hospitals from 1997 to 2009* 
Age groups 
(yrs) 
Year of first pregnant 
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total 
No. of first time pregnancies 
15-20  2029 2783 2079 2239 1923 1597 1348 963 714 480 681 698 592 18126 
20-24  2308 2950 2236 2427 2217 1840 1687 1303 999 772 1003 966 958 21666 
25-29  1233 1530 1212 1271 1088 926 842 688 581 429 605 563 500 11468 
30-34  780 918 707 753 668 523 487 370 276 259 313 293 252 6599 
35-39 365 451 408 427 338 326 284 175 174 132 158 142 130 3510 
40-50 121 161 101 140 141 142 122 88 62 44 69 73 52 1316 
Total 6836 8793 6743 7257 6375 5354 4770 3587 2806 2116 2829 2735 2484 62685 
No. of incident GDM 
15-20 47 66 36 48 39 52 32 17 16 9 12 13 11 398 
20-24  72 77 80 90 73 65 70 56 38 27 24 32 31 735 
25-29  65 66 70 77 62 66 49 33 33 31 38 43 31 664 
30-34  62 69 48 56 65 44 42 44 25 17 24 21 18 535 
35-39 24 35 39 40 25 42 29 12 18 14 13 17 13 321 
40-50 9 6 8 14 9 15 9 5 4 2 5 6 6 98 
Total 279 319 281 325 273 284 231 167 134 100 116 132 110 2751 









Table 5. Incidence (%) of GDM by age and year in the LSUHCSD Hospitals from 1997 to 2009* 
Age groups 
(yrs) 
Year of first pregnant P value 
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5.8  4.7  6.4  5.9  5.9  8.3  6.7  5.9  6.4  5.6  6.0  7.1  7.5  6.3  0.019 
*Data are given as percentage (SE); GDM: gestational diabetes mellitus; LSUHCSD: Louisiana State University Health Care Services Division. 
†Adjusted for race and year. 







The annual race-ethnicity-specific incidence of GDM is presented in Table 6. Overall, 
Asian women had a significantly higher age-standardized incidence of GDM (8.6%, P<0.001) 
than White women (6.7%) and African American women (5.4%). 
To assess the accuracy in defining GDM based on ICD 648.8 (ICD 9) in the LSUHLS 
database, we conducted a validation by using the plasma glucose testing results extracted 
from our laboratory database. Of the 2,751 GDM women who were diagnosed with GDM by 
using ICD 648.8, 1,536 GDM women that had electronic records of glucose testing values 
(the electronic records of glucose testing values were available from 2002). This validation 
was conducted among the 1,536 GDM women. Of the 1,536 women, 1,158 (75.4%) had 
GDM by using ADA GDM or diabetes diagnosis criteria.(ADA, 2003; Expert Committee on 
the Diagnosis and Classification of Diabetes Mellitus, 1997; Genuth et al., 2003), 103 (6.7%) 
had IGT, and 66 (4.3%) had IFG by using WHO (WHO Consultation, 1999) or ADA diabetes 
diagnosis criteria (Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus, 1997; Genuth et al., 2003) (Figure 1). In LSUHCSD, pregnancies complicated with 
IGT and IFG were also defined as GDM. Therefore, the agreement between the laboratory 
tests and the ICD diagnoses was 86.4% for the GDM cases.  
History of GDM and the Risk of Incident Type 2 Diabetes 
From 1990 to 2009, 19,998 women aged 13-50 years with their first record of 
pregnancy were identified from LSUHLS database. Among them, a total of 1,142 women had 
pregnancies that were complicated by GDM. During a mean follow-up of 8.6 years, 1,067 
women without a history of GDM and 327 women with a history of GDM developed diabetes. 
The general characteristics of the study population at baseline by GDM status are presented 
in table 7. After adjustment for age, GDM women had significantly higher average 




Table 6. Annual race/ethnicity-specific incidence (%) of GDM in the LSUHCSD Hospitals from 1997 to 2009* 
Year pregnant White African American Asian P value 
N/N† Incidence N/N† Incidence N/N† Incidence 
1997 64/1580 4.1 (0.5) 189/4884 3.9 (0.3) 6/71 8.5 (0.2) 0.14 
1998 69/2007 3.4 (0.4) 222/6300 3.5 (0.2) 6/90 6.7 (0.2) 0.27 
1999 68/1632 4.2 (0.5) 189/4704 4.0 (0.3) 8/67 11.9 (2.4) 0.005 
2000 91/1896 4.8 (0.5) 198/4833 4.1 (0.3) 4/80 5.0 (0.2) 0.42 
2001 72/1543 4.7 (0.5) 159/4336 3.7 (0.3) 6/75 8.0 (2.3) 0.045 
2002 72/1308 5.5 (0.6) 169/3531 4.8 (0.4) 4/66 6.1 (2.8) 0.55 
2003 56/1125 5.0 (0.6) 120/3097 3.9 (0.4) 9/53 17.0 (2.9) <0.001 
2004 34/864 3.9 (0.7) 79/2169 3.6 (0.5) 5/58 8.6 (2.8) 0.14 
2005 24/716 3.4 (0.8) 56/1541 3.6 (0.5) 4/54 7.4 (2.9) 0.31 
2006 25/657 3.8 (0.8) 30/986 3.0 (0.7) 6/40 15.0 (3.3) <0.001 
2007 41/828 5.0 (0.7) 37/1350 2.7 (0.5) 0/30 0 0.014 
2008 60/742 8.1 (0.8) 39/1506 2.6 (0.6) 0/20 0 <0.001 
2009 38/746 5.1 (0.8) 43/1351 3.2 (0.6) 3/20 15.0 (4.6) 0.004 
Total 714/15,644 4.6 (0.2) 1530/40,588 3.8 (0.1) 61/724 8.4 (0.8) <0.001 
Age-standardized‡ 714/15,644 6.7 1530/40,588 5.4 61/724 8.6 <0.001 
P value (trend) <0.001 <0.001 0.18  
*Data are given as percentage (SE); GDM: gestational diabetes mellitus; LSUHCSD: Louisiana State University Health Care Services Division. 
†Number of gestational diabetes mellitus/number of first time pregnancies. 









Table 7. Baseline and follow-up characteristics of women with and without previously diagnosed GDM who delivered a baby in LSUHCSD 
hospitals* 
Characteristics Non-GDM women GDM women P value for trend 
Participants, n 18,856 1,142  
Incident DM case, n 1,067 327  
Gestational  age, y 24.3 (0.0) 26.8 (0.2) <0.001 
Postpartum BMI, kg/m2 41.1 (0.4) 48.2 (1.7) <0.001 
Postpartum systolic blood pressure, mmHg 128 (0.1) 131 (0.6) <0.001 
Postpartum diastolic blood pressure, mmHg 76 (0.1) 76 (0.4) 0.24 
Current smoker, % 19.5 17.9 0.18 
Annual family income, $ 21,049 (452) 24,494 (1747) 0.056 
*GDM: gestational diabetes mellitus, LSUHCSD: Louisiana State University Health Care Services Division, DM: diabetes mellitus. 
  Data are means (SD) unless otherwise indicated; all data, except age, adjusted for age.
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In age-adjusted analysis, women with a history of GDM had 7.02 (95% confidence interval 
[CI] 6.18-7.96) times higher risk of type 2 diabetes compared with non-GDM women (Table 
8). Additional adjustment for smoking, income, BMI, systolic blood pressure and race did not 




Figure 1. Incidence (%) of GDM (ICD-9:648.8) based on different glucoses levels and 
diagnosed criteria in the Louisiana State University Health Care Services Division Hospitals 
from 1997 to 2009.  (GDM, gestational diabetes mellitus; Known DM, known diabetes 
mellitus; PG_2h, 2-hour plasma glucose by OGTT; FPG, fasting plasma glucose; GLU, 
random plasma glucose;  IGT, impaired glucose tolerance; IFG, impaired fasting glucose; 
OGTT, oral glucose tolerance test; GCT, glucose challenge test)
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Table 8. Hazard rations for type 2 diabetes according to GDM status for total study samples and stratified by age, BMI and race* 
 No. of case / No. of sample     Person-years Hazard ratios (95% CIs) P value 
for trend 
P for 
interaction Non-GDM women GDM women Non-GDM women GDM women Non-GDM women GDM women 
Total sample         
    Adjustment for age 1,067/18,856 327/1,142 163,703 6,503 1.00 7.02 (6.18-7.96) <0.001  
    Multivariate adjustment* 1,067/18,856 327/1,142 163,703 6,503 1.00 6.71 (5.91-7.63) <0.001  
Age (y)*        <0.001 
    13.0-29.9 669/15,233 183/776 132,139 4,204 1.00 9.31 (7.87-11.0) <0.001  
    30.0-39.9 325/3,136 131/337 27,626 2,131 1.00 5.22 (4.24-6.42) <0.001  
    40.0-50.0 73/487 13/29 3,938 167 1.00 4.43 (2.43-8.09) <0.001  
BMI (kg/m2)*        >0.50 
    <25.0 114/4,933 25/170 39,984 1,008 1.00 7.06 (4.51-11.1) <0.001  
    25.0-29.9 161/4,511 40/236 39,109 1,495 1.00 5.53 (3.86-7.91) <0.001  
    ≥30.0 792/9,412 262/736 84,610 4,000 1.00 6.76 (5.85-7.81) <0.001  
Race*        >0.10 
   African American 733/12,484 206/638 112,511 3,758 1.00 7.41 (6.33-8.68) <0.001  
   White 300/5,145 89/337 43,954 2,036 1.00 5.23 (4.10-6.67) <0.001  
   Asian American 2/114 1/20 863 109 1.00 9.84 (0.39-249) 0.165  
   Hispanic 13/452 14/71 2,826 293 1.00 9.92 (4.01-24.5) <0.001  
   Indian 8/101 4/13 939 64 1.00 6.09 (1.70-21.8) 0.005  
Race*‡        <0.025 
   African American 733/12,484 206/638 112,511 3,758 1.00 7.41 (6.33-8.68) <0.001  
   White 300/5,145 89/337 43,954 2,036 1.00 5.23 (4.10-6.67) <0.001  
*GDM: gestational diabetes mellitus, BMI: body mass index. 
†Adjusted for age, smoking, income, BMI, systolic blood pressure, race, other than the variable for stratification. 
‡The analysis was restricted to African American women and white women, 2=5.51, 1df, p <0.025. 
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There was no significant interaction of BMI and a history of GDM on the risk of type 2 
diabetes. However, there was a significant interaction between age and a history of GDM on 
risk of type 2 diabetes, which suggested that the extent of risk was stronger among women 
with gestational age 13.0-29.9 years than 30.0-50.0 years. 
In race stratified analysis, White women tended to have the lowest risk to develop 
type 2 diabetes if they had a history of GDM (Table 8). Although there was no overall 
significant interaction between race and a history of GDM on the risk of type 2 diabetes, the 
risk was significantly different between African American women and White women 
(
2
=5.51, df=1, p <0.025), suggesting that the relative risk for developing type 2 diabetes was 
higher in African American women with a history of GDM than in White women with a 
history of GDM   (Table 8). 
The incident rate of type 2 diabetes was declined over years during the postpartum 
period in both GDM and non-GDM women (Table 9), however, GDM women had higher 
incident rate at any given years compared to non-GDM women. Also, compared with non-
GDM women compartments, GDM women after delivery for <1, 1.0-3.9, 4.0-5.9 , 6.0-7.9, 8-
9.9, and ≥10.0 years had 5.31 (95% CI 3.43-8.23), 6.86 (CI 5.14-9.14), 4.92 (CI 3.27-7.39), 
3.41 (CI 2.17-5.36), 4.81 (CI 3.06-7.57), and 3.54 (2.24-5.58) times higher risk of having 
type 2 diabetes, respectively. 
Discussion 
The present study involved 62,685 pregnancies, among which 19,998 were free of 
type 2 diabetes at baseline. This study constitutes the first investigation of the GDM 
incidence and the influence of a history of GDM on subsequent type 2 diabetes in Louisiana. 
This study suggested that, among women who received medical care from the LSUHCSD 
hospitals, the incidence of GDM increased in most years from 1997 to 2009 and reached a 
peak in 2002. The incidence of GDM was highest among women at 35.0-39.9 years of age, as 
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well as in Asian Americans. This study also suggested a direct association between a history 
of GDM and the risk of type 2 diabetes. African American women with a history of GDM 
showed a higher relative risk for incident type 2 diabetes than White women with a history of 
GDM. In addition, risk of type 2 diabetes was decreased by the time after index delivery. 
In the present study, the age-standardized incidence of GDM increased from 5.8% in 
1997 to 7.5% in 2009 (increased by 29.3%), suggesting an increase in GDM incidence in 
Louisiana. According to the Department of Health and Hospitals of Louisiana, the population 
in Louisiana has a high prevalence of physical inactivity, overweight/obesity (Louisiana has 
the 4
th
 highest rate of adult obesity (Lloyd, 2010)), diabetes, high blood cholesterol, high 
blood pressure, tobacco use, and poor nutrition (Hospitals., 2009). All these factors may 
contribute to the increasing incidence of GDM in Louisiana. Due to the differences in the 
diagnostic criteria used in defining GDM, variables included in analyses, the study period and 
the study population, it is difficult to compare our results to other studies.     
Advanced age had been identified as an important risk factor of GDM by several 
studies.(Anna et al., 2008; Dabelea et al., 2005b; Ferrara et al., 2004; Getahun et al., 2008a; 
Zhang et al., 2011) While most of these studies found out that the prevalence/incidence of 
GDM increased with age, the study conducted by Zhang et al(Zhang et al., 2011) showed that 
the prevalence of GDM peaked in the 30-34 age group and declined in the group who aged 
over 35.  Similarly, in the current study, the highest incidence of GDM was observed in the 
35.0-39.9 age group instead of the 40.0-50.0 age group. Of note, the observations in both 
studies were based on much fewer pregnancies and GDM cases identified in the oldest age 
group compared with other age groups. This might explain the inconsistency between the two 
studies and other studies. 
 Like previous studies (Anna et al., 2008; Dabelea et al., 2005b; Ferrara et al., 2004), 
the present study found that the incidence of GDM was higher among Asian women than  
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Table 9. Odds ratio for type 2 diabetes according to different follow-up times after delivery* 
 Participants, n Incident DM case, n Person-years Incidence rate/1,000 
person-years 
Incidence rate ratio   
GDM/Non-GDM 
Odds Ratio† 
 Non-GDM GDM Non-GDM GDM Non-GDM GDM Non-GDM GDM  Non-GDM GDM 
GDM <1.0 y 538 149 108 77 505 96 213.9 802.1 3.75 1.00 5.31 (3.43-8.23) 
GDM 1.0-3.9 y 3,131 366 202 119 10,033 965 20.1 123.3 6.13 1.00 6.86 (5.14-9.14) 
GDM 4.0-5.9 y 2,553 158 174 44 14,537 826 12.0 53.3 4.44 1.00 4.92 (3.27-7.39) 
GDM 6.0-7.9 y 3,020 166 171 29 23,174 1,215 7.4 23.9 3.23 1.00 3.41 (2.17-5.36) 
GDM 8.0-9.9 y 3,477 135 158 32 33,575 1,235 4.7 25.9 5.51 1.00 4.81 (3.06-7.57) 
GDM ≥10.0 y 6,137 168 254 26 81,879 2,166 3.1 12.0 3.87 1.00 3.54 (2.24-5.58) 
*DM: diabetes mellitus, GDM: gestational diabetes mellitus. 









among White women and African American women. This race difference of GDM risk 
cannot be fully explained by the difference in age, family income, BMI, and smoking among 
races. A recent combined analysis of 7,414 Asian American and 140,291 non-Hispanic White 
adults indicated that Asian Indians, Chinese, and Filipinos were each more likely to develop 
diabetes than non-Hispanic Whites (Oza-Frank et al., 2009). It has been hypothesized that 
Asians have higher adiposity per unit BMI compared with other race/ethnic groups, leading 
to an increased risk of type 2 diabetes at lower BMI (WHO expert consultation, 2004). 
Besides adiposity, poor medical care, short stature and genetic factors may also contribute to 
the higher GDM incidence in Asian women.(Anastasiou et al., 1998; Chu et al., 2009; Groop 
and Orho-Melander, 2001; Jang et al., 1998) The difference of GDM rate between non-
Hispanic Whites and African Americans is inconsistent in the literature. Several studies, 
including the current one,(Chu et al., 2009; Getahun et al., 2008a; Williams et al., 1999)  
found the  GDM rate was lower in African Americans as compared with Whites, while others 
reported the opposite findings.(Dabelea et al., 2005b; Esakoff et al., 2005b; Rosenberg et al., 
2005b) However, the reason for such discrepancy is unclear and certainly deserves further 
investigations.  
Our results are consistent with previous studies and are in the same magnitude of the 
risk estimates: women with a history of GDM have an overall of 5.7-fold increased risk of 
type 2 diabetes compared with non-GDM women after the index pregnancy. Therefore, 
adequate emphasis should be attached to preventing type 2 diabetes in women with a history 
of GDM in Louisiana. 
Although several studies assessing the association between a history of GDM and 
type 2 diabetes included mixed ethnic origin subjects (Feig et al., 2008; Gunderson et al., 
2007; Lee et al., 2007; Vambergue et al., 2008), no previous study has compared the relative 
risk of developing future type 2 diabetes between African American women and White 
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women with a history of GDM. In the current study, African American women with a history 
of GDM were more prone to developing subsequent type 2 diabetes than White women with 
a history of GDM, which may partly explain the much higher prevalence of diabetes in 
African American women than that of White women (Cowie et al., 2009) even though the 
rate of GDM is a little lower in African American women than in White women (Getahun et 
al., 2008b). This is also supported by our data which indicated that the incident rate of type 2 
diabetes was similar in African American and White women who did not have a history of 
GDM.  
In the current study, parous women with a history of GDM had a marked risk of 
progressing to diabetes: 802.1 incident rate per 1000 person-years over the subsequent year, 
and 53.3-123.3 incident rate per 1000 person-years over the following 1-5 years, which is in 
line with the finding from others that the cumulative incidence of type 2 diabetes increased 
markedly in the first 5 years postpartum (Kim et al., 2002). However, there is no sign of 
plateau after 10 years (12.0 incident rate per 1000 person-years). This may be partly 
explained by different duration of follow-up, different definition of cohort, ethnic variation as 
well as difference in diagnosis criteria of GDM and type 2 diabetes. Nevertheless, our results 
provide important data to suggest the cost-effectiveness interventions among women with a 








SUMMARY AND CONCLUSION 
 
In the current study,  in  women served by the LSUHCSD hospitals, the incidence of 
GDM increased in most years from 1997 to 2009 (from 5.8% to 7.5%) and reached a peak in 
2002 (8.3%). GDM has become an important public health problem, particularly among 
women aged 35.0-39.9 years.  Furthermore, in this cohort, a history of GDM is a strong 
predictor of incident type 2 diabetes later in life. African American women with a history of 
GDM showed a higher relative risk for incident type 2 diabetes than White women with a 
history of GDM. Therefore, more effort should be put into planning and implementation of 
effective prevention and control strategies for GDM in Louisiana especially in the middle and 
low income women. A lifestyle intervention targeting women, especially for African 
American women, with a history of GDM may be effective in reducing the burden of type 2 
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